Newstral
Article
Haaretz on 2015-09-07 04:47
Antitrust body probing Teva over distribution firm
Related news
- EU antitrust authorities launch probe of Teva over Copaxone drugtimesofisrael.com
- Rx firm Teva in throes of crisisnwaonline.com
- FTeva pays $1.2bn in antitrust drugs caseft.com
- Antitrust Authority probing sharp mortgage-rate hikesisraelnationalnews.com
- EU antitrust regulators investigating Teva over its Copaxone drugThe Jerusalem Post (JPost.com)
- Teva fined $1.2 billion in US antitrust casetimesofisrael.com
- Buffett’s firm invests in drugmaker Teva, trims Phillips 66neworleanscitybusiness.com
- Teva CEO shuffles management as firm refines restructuring planThe Globe and Mail
- Teva buys Allergan generic drug firm for $40.5BUSA today
- Teva forms joint venture with Japanese drug firmbizjournals.com
- Buffett's firm invests in drugmaker Teva, trims Phillips 66kentucky.com
- Warren Buffett’s firm adds to Apple, Teva investmentsThe Findlay Courier
- Israeli firm Teva buying Auspex for $3.2 billionHaaretz
- Pharma firm Teva ordered to pay $519M over bribe dealNew York Post
- Teva makes first foray into medical cannabis sector with new distribution dealtimesofisrael.com
- Congo Probing Israeli Billionaire’s Loan to State FirmHaaretz
- German firm probing hiring of PM’s lawyer in sub dealThe Jerusalem Post (JPost.com)
- White House probing huge loans to Kushner’s family firmtimesofisrael.com